Deep venous thrombosis prophylaxis with low molecular weight heparin and elastic compression in patients having total hip replacement: A randomised controlled trial

International Angiology

Volumn 15, Issue 2, 1996, Pages 162-168

  Kalodiki, E Ph ^a   Hoppensteadt, D A ^b   Nicolaides, A N ^a   Fareed, J ^b   Gill, K ^a   Regan, F ^a   Al Kutoubi, A ^a   Cunningham, D A ^a   Birch, R ^a   Harris, N ^a   Hunt, D ^a   Johnson, J ^a   Marx, C ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Deep vein thrombosis; Elastic stockings; Heparin; Low molecular weight; Pulmonary embolism

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BANDAGE; BLOOD SAMPLING; CLINICAL TRIAL; COMPRESSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; LUNG EMBOLISM; LUNG SCINTISCANNING; LUNG VENTILATION PERFUSION RATIO; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THORAX RADIOGRAPHY; TOTAL HIP PROSTHESIS;

AGED; ANTICOAGULANTS; BANDAGES; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; ENOXAPARIN; FEMALE; HIP PROSTHESIS; HUMANS; INCIDENCE; MALE; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; THROMBOSIS;

EID: 0030003268     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction of fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic and urologic surgery. N Engl J Med 1988;318:1162-73.
2. Roberts HR. National Institutes of Health Consensus Conference. Prevention of venous thrombosis and pulmonary embolism. JAMA 1986;256:744-9.
3. Laverick MD, Croal SA, Mollan RAB. Orthopaedic surgeons and thromboprophylaxis. Br Med J 1991;303:549-50.
4. Nurmohamed MT, Rosendaal FR, Buller HR et al. Low molecular weight heparin versus standard heparin in general and orthopaedic surgery; a meta-analysis. Lancet 1992;340:152-6.
5. Leizorovicz A, Haugh MC, Capuis FR, Samama MM, Boissel JP. Low molecular weight heparin in prevention of perioperative thrombosis. Br Med J 1992;305:913-20.
6. Colditz GA, Tuden RL, Oster G. Rates of venous thrombosis after general surgery: combined results of randomised clinical trials. Lancet 1986;ii:143-6.
7. Torngren S. Low dose heparin and compression stock-ings in the prevention of postoperative deep venous thrombosis. Br J Surg 1980;67:482-4.
8. Borow M, Golsdson HJ. Prevention of postoperative deep venous thrombosis and pulmonary embolism with combined modalities. Am Surg 1983;49:599-605.
9. Wille-Jorgensen P, Thorup J, Fischer A, Holst-Christensen J, Flamsholt R. Heparin with and without graded compression stockings in the prevention of thromboembolic complications of major abdominal surgery. A randomized trial. Br J Surg 1985; 72(7):579-81.
10. Barnes RW, Brand RA, Clarke W, Hartley N, Hoak JC. Efficacy of graded-compressio antiembolism stockings in patients undergoing total hip arthroplasty. Clin Orthop 1978;132:61-7.
11. Ishak MA, Morley KD. Deep venous thrombosis after total hip arthroplasty; a prospective controlled study to determine the prophylactic effect of graded pressure stockings. Br J Surg 1981;68:429-32.
12. Lea Thomas M. Phlebography of the lower limb. Edinburgh: Churchill Livingstone, 1982.
13. Kalodiki E, Marston R, Volteas N et al. The combination of liquid crystal thermography and duplex scanning in the diagnosis of deep vein thrombosis. Eur J Vasc Surg 1992;6:311-6.
14. DeWeese JA, Rogoff SM. Phlebographic patterns in acute deep venous thrombosis of the leg. Surgery 1963;53:99-108.
15. Kalodiki E, Domjan J, Nicolaides AN et al. V/Q defects and deep venous thrombosis following total hip replacement. Clin Radiol 1995;50:400-3.
16. Walenga JM, Bara L, Samama MM, Fareed J. Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractions. Sem Throb Hemost 1985;11:100-7.
17. Behringwerke AG. Marburg Germany, TAT product brochure 1990;1-32.
18. Whitehead J. The design and analysis of sequential clinical trials. 2nd ed Chichester: Ellis Horwood, 1992.
19. Turpie AGG, Levine MN, Hirsh J et al. A randomised controlled trial of low molecular weight heparin (Enoxaparin) to prevent deep vein thrombosis in patients undergoing elective total hip surgery. N Engl J Med 1986;315:925-9.
20. Planes A, Vochelle N, Mansat C. Prevention of deep vein thrombosis (DVT) after total hip replacement (THR) by enoxaparin (Lovenox): one daily injection of 40 mg versus two daily injection of 20 mg. Thromb Haemost 1987;58:117 (abstract).
21. Planes A, Vochelle N, Mazas F et al. Prevention of postoperative venous thrombosis. A randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988;60:407-10.
22. Le Balc'h T, Landais A, Butel J, Weill D, Pascariello JC, Planes A. Enoxaparin versus standard heparine in prophylaxis of deep vein thrombosis after total hip replacement. Thromb Haemost 1987;58:241 (abstract).
23. Lassen MR, Borris LC, Christiansen HM et al. Prevention of thromboembolism in 190 hip arthroplasties. Acta Orthop Scand 1991;62:33-8.
24. Bjorgell O, Nilsson P, Nylander G et al. Phlebographic pattern of asymptomatic deep vein thrombosis 4 weeks after total hip replacement. Phlebography 1995;2(Suppl 1):699.